Computer-aided detection (CAD) developer iCAD reported record fourth-quarter sales of $6.3 million, up 294% compared with the $1.6 million turned in a year ago. For the period (end-December 31), the Nashua, NH-based firm had net income of $659,000, compared with a net loss of $1.6 million in the fourth quarter of 2003.
For the year, iCAD had sales of $23.3 million, up 258% compared with the $6.5 million posted in 2003. The company had a fiscal-year net loss of $828,000, compared with a net loss of $8.2 million in 2003.
President and CEO Scott Parr cited the introduction of its Second Look 200 platform and its ClickCAD fee-for-procedure program as key company successes in 2004.
By AuntMinnie.com staff writers
March 2, 2005
Related Reading
iCAD releases Second Look 700, January 27, 2005
iCAD releases image zoom option, December 23, 2004
iCAD adds to coffers, December 16, 2004
Viatronix, iCAD sign licensing deal, November 30, 2004
Hologic, iCAD ink development deal, November 23, 2004
Copyright © 2005 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
